Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Clinical Diagnostics
New and Established Early Detection Companies Work to Solidify their Standings: This is a Race to Watch
Building off last year's blog, this year we recap updates in the early detection (EDx) landscape that focus on last year’s developments, identify emerging players and technologies, and highlight some geographical considerations.
October 24, 2022
Blog Article
Clinical Diagnostics
New and Established Early Detection Companies Work to Solidify their Standings: This is a Race to Watch
Building off last year's blog, this year we recap updates in the early detection (EDx) landscape that focus on last year’s developments, identify emerging players and technologies, and highlight some geographical considerations.
October 24, 2022
Diagnostics Market
Liquid Biopsy
Biomarkers
DeciBio Q&A
Pharma & Biotech
Off-The-Shelf Cell Therapies: DeciBio's Q&A with Steve Kanner, Ph.D., CSO at Caribou Biosciences
Read as our experts interview with Steve Kanner, CSO at Caribou Biosciences.
October 20, 2022
DeciBio Q&A
Pharma & Biotech
Off-The-Shelf Cell Therapies: DeciBio's Q&A with Steve Kanner, Ph.D., CSO at Caribou Biosciences
Read as our experts interview with Steve Kanner, CSO at Caribou Biosciences.
October 20, 2022
Cell & Gene Tx
DeciBio News
Clinical Diagnostics
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC
DeciBio released a second edition liquid biopsy report that takes an updated and comprehensive look at the liquid biopsy (LBx) landscape.
October 19, 2022
DeciBio News
Clinical Diagnostics
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC
DeciBio released a second edition liquid biopsy report that takes an updated and comprehensive look at the liquid biopsy (LBx) landscape.
October 19, 2022
Liquid Biopsy
In The Press
DeciBio Champions Data Solutions to Give Edge to Life Science Companies
Read our feature in the Los Angeles Business Journal, as it highlights the use of our data products to leverage the increasing entry fees needed by companies to compete in a precision medicine space.
October 17, 2022
In The Press
DeciBio Champions Data Solutions to Give Edge to Life Science Companies
Read our feature in the Los Angeles Business Journal, as it highlights the use of our data products to leverage the increasing entry fees needed by companies to compete in a precision medicine space.
October 17, 2022
DeciBio News
Life Science Consulting
In The Press
People, Pipelines, and Projections: What Can Be Done To Help Emerging Therapeutics Get to Market Efficiently?
IPT asked representatives from DeciBio, Cybin, and GORE PharmBIO for their opinions on how to help get therapeutics get to market more efficiently.
October 15, 2022
In The Press
People, Pipelines, and Projections: What Can Be Done To Help Emerging Therapeutics Get to Market Efficiently?
IPT asked representatives from DeciBio, Cybin, and GORE PharmBIO for their opinions on how to help get therapeutics get to market more efficiently.
October 15, 2022
Research Tools
Next-Generation Therapeutics
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Roundup
Read our September roundup to find out more about new key developments in the Next-Generation Therapeutics Space.
October 14, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Roundup
Read our September roundup to find out more about new key developments in the Next-Generation Therapeutics Space.
October 14, 2022
Next-Generation Therapeutics
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved